Contineum Therapeutics, Inc. Contracts & Agreements

24 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement, dated February 3, 2023, by and between the Registrant and Janssen Pharmaceutica NV
License Agreements
Contineum Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2024
Contineum Therapeutics, Inc. Executive Severance Plan
Severance Agreements
Contineum Therapeutics, Inc.
2024
Form of Registrants Mutual Arbitration Agreement
Contineum Therapeutics, Inc.
2024
Form of Underwriting Agreement
Underwriting Agreements
Contineum Therapeutics, Inc.
2024
Form of Registrants Class A common stock certificate
Stock Agreements
Contineum Therapeutics, Inc.
2024
Form of Indemnity Agreement between the Registrant and each of its directors and executive officers
Contineum Therapeutics, Inc.
2024
2024 Equity Incentive Plan and form of agreements thereunder
Bonus & Incentive Agreements
Contineum Therapeutics, Inc.
2024
2024 Employee Stock Purchase Plan
Stock Agreements
Contineum Therapeutics, Inc.
2024
Offer Letter, dated as of August 14, 2018, by and between the Registrant and Carmine Stengone
Contineum Therapeutics, Inc.
2024
Offer Letter, dated as of March 9, 2018, as amended by Amendment to Original Offer Letter, dated as of December 16, 2021, each by and between the Registrant and Daniel Lorrain,...
Contineum Therapeutics, Inc.
2024
Offer Letter, dated as of August 20, 2020, by and between the Registrant and Peter Slover
Contineum Therapeutics, Inc.
2024
Amended and Restated Investors Rights Agreement, dated February 9, 2021, by and among the Registrant and the other parties thereto
Investor Rights Agreements
Contineum Therapeutics, Inc.
2024
Warrant to Purchase Stock, issued to Silicon Valley Bank, dated as of September 1, 2020
Warrant Agreements
Contineum Therapeutics, Inc.
2024
Letter Agreement, dated as of July 9, 2021, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P
Contineum Therapeutics, Inc.
2024
Amended and Restated Registration Rights Agreement dated as of July 9, 2021, by and among the Registrant and Baker Bros. Advisors LP
Registration Rights Agreements
Contineum Therapeutics, Inc.
2024
2012 Equity Incentive Plan, as amended, and forms of agreements thereunder
Bonus & Incentive Agreements
Contineum Therapeutics, Inc.
2024
Lease Agreement, dated January 3, 2018, by and between ARE-SD Region No. 44, LLC and the Registrant
Lease Agreements
Contineum Therapeutics, Inc.
2024
First Amendment to Lease dated February 16, 2018, by and between ARE-SD Region No. 44, LLC and the Registrant
Lease Agreements
Contineum Therapeutics, Inc.
2024
Second Amendment to Lease, dated April 2, 2018, by and between ARE-SD Region No. 44, LLC and the Registrant
Lease Agreements
Contineum Therapeutics, Inc.
2024
Third Amendment to Lease, dated June 15, 2021, by and between ARE-SD Region No. 44, LLC and the Registrant
Lease Agreements
Contineum Therapeutics, Inc.
2024
Lease Termination, dated October 25, 2023, by and between ARE-SD Region No. 44, LLC and the Registrant
Lease Agreements
Contineum Therapeutics, Inc.
2024
Lease Agreement, dated October 25, 2023, by and between ARE-3535/3566 General Atomics Court, LLC and the Registrant
Lease Agreements
Contineum Therapeutics, Inc.
2024
Loan and Security Agreement, dated as of September 1, 2020, by and between the Registrant and Silicon Valley Bank
Loan Agreements
Contineum Therapeutics, Inc.
2024
First Amendment to Loan and Security Agreement, dated as of March 15, 2021, by and between the Registrant and Silicon Valley Bank
Loan Agreements
Contineum Therapeutics, Inc.
2024